Sotatercept for treating pulmonary arterial hypertension [ID6163]

  • In development
  • GID-TA11103
  • Expected publication date: TBC

NICE has paused the evaluation of sotatercept for treating pulmonary arterial hypertension [ID6163] because the company and NHSE have commenced commercial discussions.

Please note that following a call between NICE and the company, the timelines for ID6163 - Sotatercept for treating pulmonary arterial hypertension, have been revised. A new invitation to participate will be sent out in January 2025.